29/02/2024
In a comprehensive 28-day global clinical trial with 200 participants, the GFOUK™ SugarSync Health Control Aerosolizer demonstrated a significant reduction in fasting blood sugar levels when compared to placebo in a randomized, double-blind, placebo-controlled study involving 200 type 2 diabetics.
https://www.marktemusik.info/products/sugarsyncjb1